CVS

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Representative image of a patient using a telehealth consultation alongside generic prescription medicines, illustrating GoodRx Holdings’ push into subscription-based digital healthcare through GoodRx Companion.

GoodRx Companion takes on Amazon Pharmacy with $14.99 generics-plus-telehealth bundle

GoodRx launches Companion at $14.99 monthly with 200 free generics and $19 telehealth visits, pushing past coupons toward recurring revenue and bundled care. Read more.

bySrinath

May 28, 2026

Representative image of IBM's AI governance and security headquarters, where the watsonx.governance and Guardium AI Security platforms are reshaping compliance architecture for regulated industries.

How IBM beat expectations in Q4 2025 with AI, z17, and productivity — and what’s next in 2026

IBM posts record free cash flow, 9% Q4 revenue growth, and $12.5B in AI business. Find out how its software-led strategy is shaping 2026 now.

bySrinath

January 29, 2026

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

GoodRx Companion takes on Amazon Pharmacy with $14.99 generics-plus-telehealth bundle

How IBM beat expectations in Q4 2025 with AI, z17, and productivity — and what’s next in 2026

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Flotek secures 10-year Puerto Rico power role as $400m backlog tests PWRtek strategy

Qualcomm’s $3.1bn Modular deal puts AI software at centre of data centre push

Ballymore Resources (ASX: BMR) extends Torpy’s high-grade silver system as 20 drill assays remain pending

Braveheart Bio IPO targets $1.2bn valuation as HCM drug race heats up